Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,705 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06065215Recruiting
Early-life MRI to Predict Breathing Problems in Extremely Preterm Infants
This study uses an MRI scan to look at how the lungs develop in babies born very early (before 29 weeks of pregnancy). The goal is to see if early MRI images can help predict future breathing problems, so doctors can better support these infants.
Ottawa, OntarioAges 8 months–1.8 years - NCT06066905Recruiting
Study of chidamide and azacitidine for AML patients with MRD after transplant
This trial tests whether a combination of two drugs, chidamide and azacitidine (AZA), can help people with acute myeloid leukemia (AML) who still have small amounts of leukemia cells (called MRD) after a stem cell transplant. The goal is to see if this treatment can clear those leftover cells and lower the chance of the leukemia coming back.
Guangzhou, GuangdongAges 18 years+ - NCT06066918Recruiting
Preventing pain after spinal cord injury with Pregabalin
This study tests if taking Pregabalin early after a spinal cord injury can prevent pain from developing. It's a drug that may help calm nerve signals.
RaananaAges 18 years+ - NCT06066970Recruiting
Studying heart markers after valve surgery
This trial uses a special MRI and blood tests to see how heart muscle is affected after aortic or mitral valve surgery. It may help doctors better understand and monitor heart recovery.
Freiburg im Breisgau, Baden-WurttembergAges 18 years+ - NCT06067529Recruiting
Study on the health effects of early menopause
This study follows women with premature ovarian insufficiency (POI) over time to understand how it affects their health. Researchers will collect samples and track health changes to learn more about the condition and its long-term effects.
Hangzhou, ZhejiangAges 10–65 - NCT06067867Recruiting
Kidney and pregnancy registry study
This study tracks the health of women with kidney problems before, during, and after pregnancy to learn how to better care for them. It is for women who have had kidney disease, high blood pressure, certain pregnancy complications, or a kidney transplant.
BrusselsAges 18 years+ - NCT06067789Recruiting
Testing spinal vs. general anesthesia for leg blood flow surgery
This study tests a new way to give anesthesia during leg surgery to improve blood flow. It aims to see if spinal anesthesia works better than general anesthesia for recovery and comfort.
Ottawa, OntarioAges 18 years+ - NCT06068179RecruitingPhase 2/Phase 3
Can a new combo help Graves' disease go into remission?
This trial tests a combination of two medicines (methimazole and mycophenolate) to see if they can help people with newly diagnosed Graves' disease go into remission faster and more safely. If you are newly diagnosed and haven't had treatment yet, this study might offer a way to get better control of your condition.
Xiamen, FujianAges 18–60 - NCT06068764RecruitingPhase 4
Comparing Two Anesthesia Drugs for Bypass Surgery
This study compares two common anesthesia medicines (etomidate and propofol) for patients having planned coronary artery bypass surgery. The goal is to see which medication works better for your heart and recovery.
Hartford, ConnecticutAges 18–90 - NCT06069830Recruiting
PET scan and EBV test guided treatment for nasal NK/T cell lymphoma
This trial uses PET scans and EBV DNA levels to personalize treatment for patients with early-stage nasal NK/T cell lymphoma. It aims to reduce side effects by adjusting therapy based on how well the cancer responds.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06069622Recruiting
How a gene affects weight-loss treatment response
This study looks at how a weight-loss medication affects people with obesity who may have a specific gene difference (caveolin-1). It aims to understand why some people respond differently to GLP-1 treatments like semaglutide.
Boston, MassachusettsAges 18 years+ - NCT06069973Recruiting
Using AI to spot delayed brain injury after a brain bleed
This study uses artificial intelligence (machine learning) and blood tests to find early signs of delayed brain injury after a brain bleed. It aims to help doctors detect and treat this complication sooner.
GothenburgAges 18–110 - NCT06070467Recruiting
Understanding daily life of children with rare eye disease
This study looks at how children with rare eye diseases experience their daily lives. It aims to understand their real-life challenges and feelings through interviews and questionnaires.
StrasbourgAges 8 years+ - NCT06070428Recruiting
A study on heart failure care after hospital discharge
This trial tests a new care approach for people with heart failure who are in the hospital or emergency room and planning to go home. The goal is to see if it helps them recover and stay healthy.
Detroit, MichiganAges 18 years+ - NCT06070558Recruiting
Study of normal and abnormal jaw joint motion using real-time MRI
This study uses real-time MRI to take detailed images of your jaw joint (the temporomandibular joint) to better understand its normal and painful variations. It may help if you have jaw pain or clicking, but you don't need to have a problem to join.
NancyAges 18 years+ - NCT06071013RecruitingPhase 1/Phase 2
Nintedanib plus EGFR inhibitor for EGFR-mutated lung cancer
This trial tests a combination of two drugs—nintedanib and an EGFR inhibitor—for people with EGFR-mutated non-small cell lung cancer whose cancer has stopped responding to their first EGFR inhibitor treatment. The goal is to see if adding nintedanib can help control the cancer again.
TaichungAges 20–70 - NCT06071858Recruiting
Enhanced coordinated care for early psychosis
This trial studies an enhanced version of coordinated specialty care (CSC) for people experiencing their first episode of psychosis. It aims to improve outcomes by providing more intensive support and coordination among different healthcare providers.
Belmont, MassachusettsAges Any age - NCT06072586RecruitingEarly Phase 1
Study of BDTX-1535 for brain tumors with EGFR changes
This trial tests a new drug, BDTX-1535, for people with a type of brain tumor called high-grade glioma that has a specific change in the EGFR gene. The study looks at how the drug works in the body and how safe it is for both newly diagnosed and recurrent tumors.
Chandler, ArizonaAges 18 years+ - NCT06072703Recruiting
Brain stimulation for bladder control in MS
This study tests whether a type of brain stimulation can improve bladder control in women with multiple sclerosis. If you have bladder symptoms like urgency or frequent urination, this trial may help find new ways to manage them.
Houston, TexasAges 18 years+ - NCT06072976Recruiting
How feeding affects gut health in babies with bowel conditions
This study looks at whether breast milk or formula helps babies with certain bowel problems heal faster and reach full feeds sooner. It compares how different milk affects the bacteria in a baby's gut.
Seattle, WashingtonAges birth–55 years - NCT06073171Recruiting
Genes and skin pattern study for cutis tricolor
This study looks at the genes of people with cutis tricolor, a rare skin condition with three colors, to understand what causes it. You and your parents (one affected, one not) can help by donating a blood sample for DNA analysis.
MontpellierAges 4–60 - NCT06073106Recruiting
Frailty prevention study for older Asian adults
This trial tests a program to prevent frailty in people aged 50 and older of Asian descent who have recently been diagnosed with a stroke, traumatic brain injury, knee osteoarthritis, or breast cancer. The goal is to help you stay strong and healthy as you recover.
Singapore, SingaporeAges 50 years+ - NCT06073938Recruiting
Compassionate Use of NHWD-870 for NUT-Positive Tumors
This trial offers early access to an experimental drug called NHWD-870 for people with advanced solid tumors or lymphomas that have a specific genetic change called a NUT rearrangement. The goal is to see if this drug can help shrink or slow the growth of these cancers.
Changsha, HunanAges 18–75 - NCT06074692RecruitingPhase 2
PARP inhibitor, SBRT, and immunotherapy for advanced sarcoma
This trial tests a combination of a PARP inhibitor drug, targeted radiation (SBRT), and immunotherapy for people with advanced sarcoma that has spread. It aims to see if this triple therapy can shrink tumors or slow the disease.
Shanghai, Shanghai MunicipalityAges 10–70
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,705 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.